# Regeneron Pharmaceuticals revenue entity: /record/regeneron-pharmaceuticals.md predicate: revenue page: /record/regeneron-pharmaceuticals/revenue as_of: 2026-11-09 cite: AsOf. "Regeneron Pharmaceuticals quarterly revenue: 5,115,800,000 United States dollar", as of 2026-09-30. Claim clm_15BDC7B1496E, https://asof.is/claim/clm_15BDC7B1496E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm. As of November 9, 2026, the latest revenue figure on the AsOf record for Regeneron Pharmaceuticals is $5.12 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). Regeneron Pharmaceuticals's latest full-year revenue is $14.34 billion, dated December 31, 2025, from a primary source (sec.gov); the two periods are kept apart, never compared. 18 claims on Regeneron Pharmaceuticals's revenue, 1 open and 17 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted. ## Latest revenue The newest figure for a shorter period, the quarter ended September 30, 2026: a quarterly_revenue claim, kept apart from the full-year series. Every quarterly revenue figure: /record/regeneron-pharmaceuticals/quarterly_revenue.md - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 5,115,800,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_15BDC7B1496E](/claim/clm_15BDC7B1496E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm ## Latest full-year revenue What the record asserts on 2026-11-09. - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 14,342,900,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_E5421E95D3E6](/claim/clm_E5421E95D3E6.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm ## Every dated value One claim per line, oldest first. Superseded claims stay visible. - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 238,457,000 United States dollar | valid 2008-12-31 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_F4AAD27D2977](/claim/clm_F4AAD27D2977.md) | [clm_BC2C8A20F65B](/claim/clm_BC2C8A20F65B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 379,268,000 United States dollar | valid 2009-12-31 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_9A959E160676](/claim/clm_9A959E160676.md) | [clm_F4AAD27D2977](/claim/clm_F4AAD27D2977.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 459,074,000 United States dollar | valid 2010-12-31 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_32D9C9A4307F](/claim/clm_32D9C9A4307F.md) | [clm_9A959E160676](/claim/clm_9A959E160676.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 445,824,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_0B45DD87AE68](/claim/clm_0B45DD87AE68.md) | [clm_32D9C9A4307F](/claim/clm_32D9C9A4307F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412000709/0001206774-12-000709-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 1,378,477,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_9AAE36CED876](/claim/clm_9AAE36CED876.md) | [clm_0B45DD87AE68](/claim/clm_0B45DD87AE68.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000004/0001532176-13-000004-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 2,104,745,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_81193541BA7F](/claim/clm_81193541BA7F.md) | [clm_9AAE36CED876](/claim/clm_9AAE36CED876.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000008/0001532176-14-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 2,819,557,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_DA3C150446BB](/claim/clm_DA3C150446BB.md) | [clm_81193541BA7F](/claim/clm_81193541BA7F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000008/0001532176-15-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 4,103,728,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_CF6C0D5C4B30](/claim/clm_CF6C0D5C4B30.md) | [clm_DA3C150446BB](/claim/clm_DA3C150446BB.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000045/0001532176-16-000045-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 4,860,427,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_246434942F91](/claim/clm_246434942F91.md) | [clm_CF6C0D5C4B30](/claim/clm_CF6C0D5C4B30.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000008/0001532176-17-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 5,872,227,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_002F725B2106](/claim/clm_002F725B2106.md) | [clm_246434942F91](/claim/clm_246434942F91.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000013/0001532176-18-000013-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 6,710,800,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_98C359CB4FBA](/claim/clm_98C359CB4FBA.md) | [clm_002F725B2106](/claim/clm_002F725B2106.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000009/0001532176-19-000009-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 7,863,400,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_9C8093C9515A](/claim/clm_9C8093C9515A.md) | [clm_98C359CB4FBA](/claim/clm_98C359CB4FBA.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217620000008/0001532176-20-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 8,497,100,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_99583435A585](/claim/clm_99583435A585.md) | [clm_9C8093C9515A](/claim/clm_9C8093C9515A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000008/0001804220-21-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 16,071,700,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_6E857BE187DF](/claim/clm_6E857BE187DF.md) | [clm_99583435A585](/claim/clm_99583435A585.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000007/0001804220-22-000007-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 12,172,900,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_0A05777F6B3A](/claim/clm_0A05777F6B3A.md) | [clm_6E857BE187DF](/claim/clm_6E857BE187DF.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000008/0001804220-23-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 13,117,200,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_EE95AAD2339E](/claim/clm_EE95AAD2339E.md) | [clm_0A05777F6B3A](/claim/clm_0A05777F6B3A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/0001804220-24-000009-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 14,202,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_E5421E95D3E6](/claim/clm_E5421E95D3E6.md) | [clm_EE95AAD2339E](/claim/clm_EE95AAD2339E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 14,342,900,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_E5421E95D3E6](/claim/clm_E5421E95D3E6.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm ## What replaced what - $238.46 million (2008-12-31 to 2009-12-31, [clm_BC2C8A20F65B](/claim/clm_BC2C8A20F65B.md)) was replaced by $379.27 million from 2009-12-31 ([clm_F4AAD27D2977](/claim/clm_F4AAD27D2977.md)) - $379.27 million (2009-12-31 to 2010-12-31, [clm_F4AAD27D2977](/claim/clm_F4AAD27D2977.md)) was replaced by $459.07 million from 2010-12-31 ([clm_9A959E160676](/claim/clm_9A959E160676.md)) - $459.07 million (2010-12-31 to 2011-12-31, [clm_9A959E160676](/claim/clm_9A959E160676.md)) was replaced by $445.82 million from 2011-12-31 ([clm_32D9C9A4307F](/claim/clm_32D9C9A4307F.md)) - $445.82 million (2011-12-31 to 2012-12-31, [clm_32D9C9A4307F](/claim/clm_32D9C9A4307F.md)) was replaced by $1.38 billion from 2012-12-31 ([clm_0B45DD87AE68](/claim/clm_0B45DD87AE68.md)) - $1.38 billion (2012-12-31 to 2013-12-31, [clm_0B45DD87AE68](/claim/clm_0B45DD87AE68.md)) was replaced by $2.1 billion from 2013-12-31 ([clm_9AAE36CED876](/claim/clm_9AAE36CED876.md)) - $2.1 billion (2013-12-31 to 2014-12-31, [clm_9AAE36CED876](/claim/clm_9AAE36CED876.md)) was replaced by $2.82 billion from 2014-12-31 ([clm_81193541BA7F](/claim/clm_81193541BA7F.md)) - $2.82 billion (2014-12-31 to 2015-12-31, [clm_81193541BA7F](/claim/clm_81193541BA7F.md)) was replaced by $4.1 billion from 2015-12-31 ([clm_DA3C150446BB](/claim/clm_DA3C150446BB.md)) - $4.1 billion (2015-12-31 to 2016-12-31, [clm_DA3C150446BB](/claim/clm_DA3C150446BB.md)) was replaced by $4.86 billion from 2016-12-31 ([clm_CF6C0D5C4B30](/claim/clm_CF6C0D5C4B30.md)) - $4.86 billion (2016-12-31 to 2017-12-31, [clm_CF6C0D5C4B30](/claim/clm_CF6C0D5C4B30.md)) was replaced by $5.87 billion from 2017-12-31 ([clm_246434942F91](/claim/clm_246434942F91.md)) - $5.87 billion (2017-12-31 to 2018-12-31, [clm_246434942F91](/claim/clm_246434942F91.md)) was replaced by $6.71 billion from 2018-12-31 ([clm_002F725B2106](/claim/clm_002F725B2106.md)) - $6.71 billion (2018-12-31 to 2019-12-31, [clm_002F725B2106](/claim/clm_002F725B2106.md)) was replaced by $7.86 billion from 2019-12-31 ([clm_98C359CB4FBA](/claim/clm_98C359CB4FBA.md)) - $7.86 billion (2019-12-31 to 2020-12-31, [clm_98C359CB4FBA](/claim/clm_98C359CB4FBA.md)) was replaced by $8.5 billion from 2020-12-31 ([clm_9C8093C9515A](/claim/clm_9C8093C9515A.md)) - $8.5 billion (2020-12-31 to 2021-12-31, [clm_9C8093C9515A](/claim/clm_9C8093C9515A.md)) was replaced by $16.07 billion from 2021-12-31 ([clm_99583435A585](/claim/clm_99583435A585.md)) - $16.07 billion (2021-12-31 to 2022-12-31, [clm_99583435A585](/claim/clm_99583435A585.md)) was replaced by $12.17 billion from 2022-12-31 ([clm_6E857BE187DF](/claim/clm_6E857BE187DF.md)) - $12.17 billion (2022-12-31 to 2023-12-31, [clm_6E857BE187DF](/claim/clm_6E857BE187DF.md)) was replaced by $13.12 billion from 2023-12-31 ([clm_0A05777F6B3A](/claim/clm_0A05777F6B3A.md)) - $13.12 billion (2023-12-31 to 2024-12-31, [clm_0A05777F6B3A](/claim/clm_0A05777F6B3A.md)) was replaced by $14.2 billion from 2024-12-31 ([clm_EE95AAD2339E](/claim/clm_EE95AAD2339E.md)) - $14.2 billion (2024-12-31 to 2025-12-31, [clm_EE95AAD2339E](/claim/clm_EE95AAD2339E.md)) was replaced by $14.34 billion from 2025-12-31 ([clm_E5421E95D3E6](/claim/clm_E5421E95D3E6.md)) ## Questions this record answers ### What is Regeneron Pharmaceuticals's current revenue? The latest figure on the record is $5.12 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). The latest full-year figure is $14.34 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts both as of November 9, 2026. ### What was Regeneron Pharmaceuticals's revenue for the quarter ended September 30, 2026? $5.12 billion for the quarter ended September 30, 2026, dated September 30, 2026, from a primary source (sec.gov) (status valid, confidence 0.95). ### When did Regeneron Pharmaceuticals's revenue last change? The latest value on the record is $14.34 billion, dated December 31, 2025; before it the record holds $14.2 billion, dated December 31, 2024 and closed on December 31, 2025. ### What was Regeneron Pharmaceuticals's revenue before $14.34 billion? $14.2 billion, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov). ## Read on - This page: /record/regeneron-pharmaceuticals/revenue (markdown: /record/regeneron-pharmaceuticals/revenue.md) - Entity twin: /record/regeneron-pharmaceuticals.md ยท timeline: /timelines/regeneron-pharmaceuticals.md - Every company's revenue: /facts/revenue.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.